In-vitro cardiopulmonary combined perfusion system and perfusion method

An in vitro, cardiopulmonary technology, applied in the field of organ transplantation, can solve the problems of lack of disease models, lack of real anatomical organs, and inability to perfuse and preserve isolated cardiopulmonary organs at the same time.

CN112106766AActive Publication Date: 2020-12-22奇点医疗科技(广州)有限公司
7 Cites 2 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
Publication Date
2020-12-22

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention aims to provide an in-vitro cardiopulmonary combined perfusion system and a perfusion method. The in-vitro organs are preserved by using an organ perfusion method, ischemia reperfusion injury caused by low-temperature preservation is avoided, and the problem that the in-vitro cardiopulmonary organs cannot be perfused and preserved at the same time is solved. The system comprises an organ cabin, a circulation cabin, a control cabin, a simple breathing cabin, a cardiac pacemaker body, a development and control panel and a base, the organ cabin is connected with the circulation cabin, the control cabin and the simple breathing cabin, and the control cabin is connected with the development and control panel. The organ cabin, the circulation cabin, the control cabin, the simple breathing cabin and the imaging and control panel are installed on the base, the simple breathing machine is placed in the simple breathing cabin, and the simple breathing machine and the cardiac pacemaker are respectively connected with the in-vitro cardiopulmonary to form an in-vitro cardiopulmonary support system. The cardiac pacemaker monitors and outputs a signal to the control cabin, and the control cabin controls the work of the cardiac pacemaker.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the technical field of organ transplantation, in particular to an isolated heart-lung combined perfusion system and a perfusion method. Background technique

[0002] Organ transplantation is an effective means of treating end-stage organ diseases. At present, about 300,000 people are still waiting for organ transplantation, so every donor is very precious, so it is very important to do a good job in perfusion preservation of donors.

[0003] With the development of heart and lung transplantation technology, more and more attention has been paid to the protection of donor heart and lung. The preservation quality of donor heart and lung directly affects the survival rate of patients after organ transplantation. At present, in clinical practice, the isolated heart and lungs are mainly preserved by low temperature immersion in organ preservation solution. Storage time in vitro. However, the low temperature storage time is general...

Examples

Embodiment Construction

[0042] In order to more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the drawings and technical solutions that need to be used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the following descriptions The drawings are only some embodiments of the present invention, and those skilled in the art can obtain other drawings according to these drawings without any creative effort.

[0043] The present invention will be further described below in conjunction with the accompanying drawings.

[0044] Such as figure 1 , 2 As shown, an isolated heart-lung combined perfusion system is designed to provide a physiological environment similar to the normal human body for the isolated heart and lung at the same time, and intelligently maintain the long-term environment of the isolated heart and lung. It is stable and can be used for combined preservation of isolated hearts and lu...